Health
Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant – News-Medical.Net
In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against…
In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against the variant B.1.1.7 of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) initially found in the United Kingdom – and revealed diminished recognition and neutralization of either parental strains or the South African variant.
The ceaseless pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 still has a…
-
Business18 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News18 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business14 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News16 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses